<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03853330</url>
  </required_header>
  <id_info>
    <org_study_id>Analgesia for Fracture Ribs</org_study_id>
    <nct_id>NCT03853330</nct_id>
  </id_info>
  <brief_title>Erector Spinae Plane Block Versus Thoracic Epidural Analgesia in Patients With Multiple Fracture Ribs</brief_title>
  <official_title>Erector Spinae Plane Block Versus Thoracic Epidural Analgesia in Patients With Multiple Fracture Ribs</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assiut University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assiut University</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To assess the analgesic and respiratory effect of continuous Erector Spinae Plane block
      versus Thoracic Epidural in patients with multiple fracture ribs.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Erector spinae plane (ESP) block is a recently described technique which may be an
      alternative to Paravertebral block (PVB) for providing thoracic analgesia. It involves
      injection of local anesthetic into the fascial plane deep to erector spinae muscle. ESP is a
      more superficial block with a better defined end-point injection between the bony transverse
      process and erector spinae muscle. A more superficial ultrasound-guided block will be faster
      to perform and less painful for the patient. ESP does not have the same risk of pneumothorax
      as PVB.

      Epidural analgesia has become the standard of care. Although thoracic epidurals provide
      excellent analgesia for the management of rib fractures, they are limited to a certain
      population due to patient factors and side-effects. Many trauma patients have other injuries
      which contraindicate the use of epidurals, or which prevent positioning for insertion. There
      are disadvantages to thoracic epidural analgesia. They are technically challenging to insert,
      with a risk of dural puncture or spinal cord injury. Adverse effects include hypotension, and
      if opioids used, urinary retention and pruritus. Patients can develop a motor block and are
      unable to mobilize with an epidural in situ.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 1, 2019</start_date>
  <completion_date type="Anticipated">December 1, 2021</completion_date>
  <primary_completion_date type="Anticipated">October 1, 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
    <masking_description>prospective, double-blinded controlled trial; both the patient and data collector is unaware of the study nature</masking_description>
  </study_design_info>
  <primary_outcome>
    <measure>Pain score (verbal numeric rating scale) as the median VNRS at rest and cough</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>All patients will be assessed for pain score using the 11 points verbal numeric rating scale (VNRS), where zero equals no pain and 10 equals the worst pain imaginable. This assessment will be done before the block and after the block by 60 minutes and then every 6 hours up to 24 hours.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Pulmonary function test</measure>
    <time_frame>up to 24 hours</time_frame>
    <description>Pulmonary function test will be done before the block, 60 minutes after the block and then every 6 hours up to 24 hours.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">50</enrollment>
  <condition>Fracture; Rib, Multiple</condition>
  <arm_group>
    <arm_group_label>Thoracic Epidural Analgesia group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>25 patients will receive ultrasound-guided thoracic epidural analgesia for multiple fracture ribs at the level of T8 with 7.5-12 ml of Bupivacaine HCl Inj 0.25% as a loading dose followed by catheter insertion and infusion of Bupivacaine Hydrochloride, 0.125%-0.9% Injectable Solution at 5-7 ml/h. For breakthrough pain bolus of Bupivacaine Hydrochloride, 0.125%-0.9% Injectable Solution 5-10 ml can be used.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Erector spinae plane block group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>25 patients will receive ultrasound-guided ESP block for multiple fracture ribs at the level from T1 to T5 with 7.5-12 ml of Bupivacaine HCl Inj 0.25% as a loading dose followed by catheter insertion and infusion of Bupivacaine Hydrochloride, 0.125%-0.9% Injectable Solution at 5-7 ml/h. For breakthrough pain bolus of Bupivacaine Hydrochloride, 0.125%-0.9% Injectable Solution 5-10 ml can be used.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Ultrasound</intervention_name>
    <description>Ultrasound-guided Thoracic Epidural Analgesia and Erector spinae plane block.</description>
    <arm_group_label>Erector spinae plane block group</arm_group_label>
    <arm_group_label>Thoracic Epidural Analgesia group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine HCl Inj 0.25%</intervention_name>
    <description>Bupivacaine HCl Inj 0.25% will be used in both blocks by the same dose of 7.5-12 ml</description>
    <arm_group_label>Erector spinae plane block group</arm_group_label>
    <arm_group_label>Thoracic Epidural Analgesia group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Bupivacaine Hydrochloride, 0.125%-0.9% Injectable Solution</intervention_name>
    <description>infusion of Bupivacaine Hydrochloride, 0.125%-0.9% Injectable Solution at 5-7 ml/h will be used in both blocks and also for breakthrough pain after both blocks as a bolus of 5-10 ml.</description>
    <arm_group_label>Erector spinae plane block group</arm_group_label>
    <arm_group_label>Thoracic Epidural Analgesia group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with multiple fracture ribs.

        Exclusion Criteria:

          -  Patient refusal.

          -  Patients with pre-existing infection at the block site.

          -  Coagulopathy.

          -  Allergy to local anesthetics.

          -  Pre-existing neurological deficits.

          -  Psychiatric illness.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>40 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Ahmed M. Rida Abd El-Aziz Morsi, Registrar</last_name>
    <phone>+201067680970</phone>
    <email>ahmedrida_1281984@yahoo.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Rasha A. Ali Hamed, Lecturer</last_name>
    <phone>+201000440773</phone>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Assiut University Hospital</name>
      <address>
        <city>Assiut</city>
        <zip>71111</zip>
        <country>Egypt</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ahmed Rida</last_name>
      <phone>+201067680970</phone>
      <email>ahmedrida_1281984@yahoo.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Egypt</country>
  </location_countries>
  <verification_date>January 2020</verification_date>
  <study_first_submitted>February 20, 2019</study_first_submitted>
  <study_first_submitted_qc>February 22, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">February 25, 2019</study_first_posted>
  <last_update_submitted>January 7, 2020</last_update_submitted>
  <last_update_submitted_qc>January 7, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">January 9, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Assiut University</investigator_affiliation>
    <investigator_full_name>Ahmed Mohamed Rida Abd El-Aziz Morsi</investigator_full_name>
    <investigator_title>Registrar in Anesthesia and ICU</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Fractures, Bone</mesh_term>
    <mesh_term>Fractures, Multiple</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Bupivacaine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

